CEFOXITIN injection, powder, for solution United States - English - NLM (National Library of Medicine)

cefoxitin injection, powder, for solution

hikma pharmaceuticals usa inc. - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - cefoxitin 1 g - cefoxitin for injection, usp is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. (1) lower respiratory tract infections, including pneumonia and lung abscess, caused by streptococcus pneumoniae, other streptococci (excluding enterococci, e.g., enterococcus faecalis [formerly streptococcus faecalis ]), staphylococcus aureus (including penicillinase-producing strains), escherichia coli, klebsiella species, haemophilus influenzae, and bacteroides species. (2) urinary tract infections caused by escherichia coli, klebsiella species, proteus mirabilis, morganella morganii, proteus vulgaris and providencia species (including p. rettgeri ). (3) intra-abdominal infections, including peritonitis and intra-abdominal abscess, caused by escherichia coli, klebsiella species, bacteroides species including bacteroides fragilis, and clostridium species. (4) gynecological infections, including endometritis, pelvic cell

CEFOXITIN AND DEXTROSE- cefoxitin sodium injection, solution United States - English - NLM (National Library of Medicine)

cefoxitin and dextrose- cefoxitin sodium injection, solution

b. braun medical inc. - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - cefoxitin 1 g in 50 ml - cefoxitin for injection and dextrose injection is indicated for the treatment of lower respiratory tract infections, including pneumonia and lung abscess, caused by streptococcus pneumoniae , other streptococci (excluding enterococci, e.g., enterococcus faecalis [formerly streptococcus faecalis ]), staphylococcus aureus (including penicillinase-producing strains), escherichia coli , klebsiella species, haemophilus influenzae , and bacteroides species. cefoxitin for injection and dextrose injection is indicated for the treatment of urinary tract infections caused by escherichia coli , klebsiella species, proteus mirabilis , morganella morganii , proteus vulgaris and providencia species (including p. rettgeri ). cefoxitin for injection and dextrose injection is indicated for the treatment of intra-abdominal infections, including peritonitis and intra-abdominal abscess, caused by escherichia coli, klebsiella species, bacteroides species including bacteroides fragilis , and clostridium species. cefoxi

CEFOXITIN JUNO cefoxitin (as sodium) 2 g powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cefoxitin juno cefoxitin (as sodium) 2 g powder for injection vial

juno pharmaceuticals pty ltd - cefoxitin sodium, quantity: 2.103 g - injection, powder for - excipient ingredients: - cefoxitin sodium for injection is indicated for the treatment of the following infections when due to susceptible organisms (see microbiology): peritonitis and other intra-abdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, and skin and skin structure infections. cefoxitin sodium for injection has a high degree of stability against beta-lactamase and therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. it can also be used in mixed infections provided that the organisms are sensitive to it. cefoxitin sodium can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes or anaerobes. cefoxitin sodium for injection is also indicated for the prevention of post-operative infections associated with certain surgical procedures of the gastrointestinal, biliary and genital tracts.

CEFOXITIN JUNO cefoxitin (as sodium) 1 g powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cefoxitin juno cefoxitin (as sodium) 1 g powder for injection vial

juno pharmaceuticals pty ltd - cefoxitin sodium, quantity: 1.051 g - injection, powder for - excipient ingredients: - cefoxitin sodium for injection is indicated for the treatment of the following infections when due to susceptible organisms (see microbiology): peritonitis and other intra-abdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, and skin and skin structure infections. cefoxitin sodium for injection has a high degree of stability against beta-lactamase and therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. it can also be used in mixed infections provided that the organisms are sensitive to it. cefoxitin sodium can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes or anaerobes. cefoxitin sodium for injection is also indicated for the prevention of post-operative infections associated with certain surgical procedures of the gastrointestinal, biliary and genital tracts.

CONVENIA Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

convenia

zoetis australia pty ltd - cefovecin as sodium salt - parenteral liquid/solution/suspension - cefovecin as sodium salt antibiotic active 80.0 mg/ml - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacterial skin disease | escherichia coli (e. coli) | infections of the urinary tracts | infections sensitive to cefovecin | porphyromonas spp | prevotella spp | proteus mirabilis | staphylococcus intermedius | streptococcus canis | deep pyodermas | escherichia coli | group d streptococcus | including b-lactamase producin | including secondary invaders | klebsiella spp. | proteus spp. | pseudomonas aeruginosa | seborrhoeic dermatitis | staphylococcus spp.

Cefoxitin Actavis New Zealand - English - Medsafe (Medicines Safety Authority)

cefoxitin actavis

teva pharma (new zealand) limited - cefoxitin sodium 1 g - powder for injection - 1 g - active: cefoxitin sodium 1 g - cefoxitin actavis is indicated for the treatment of the following infections when due to susceptible organisms (see microbiology) peritonitis and other intra-abdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, skin and skin structure infections. cefoxitin actavis has a high degree of stability against beta-lactamase and is therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. it can also be used in mixed infections provided that the organisms are sensitive to it. cefoxitin actavis can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes, or anaerobes.

Cefoxitin Actavis New Zealand - English - Medsafe (Medicines Safety Authority)

cefoxitin actavis

teva pharma (new zealand) limited - cefoxitin sodium 2 g - powder for injection - 2 g - active: cefoxitin sodium 2 g - cefoxitin actavis is indicated for the treatment of the following infections when due to susceptible organisms (see microbiology) peritonitis and other intra-abdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, skin and skin structure infections. cefoxitin actavis has a high degree of stability against beta-lactamase and is therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. it can also be used in mixed infections provided that the organisms are sensitive to it. cefoxitin actavis can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes, or anaerobes.

CEFOXITIN FOR INJECTION POWDER FOR SOLUTION Canada - English - Health Canada

cefoxitin for injection powder for solution

teva canada limited - cefoxitin (cefoxitin sodium) - powder for solution - 1g - cefoxitin (cefoxitin sodium) 1g - cephamycins

CEFOXITIN FOR INJECTION POWDER FOR SOLUTION Canada - English - Health Canada

cefoxitin for injection powder for solution

teva canada limited - cefoxitin (cefoxitin sodium) - powder for solution - 2g - cefoxitin (cefoxitin sodium) 2g - cephamycins

CEFOXITIN FOR INJECTION POWDER FOR SOLUTION Canada - English - Health Canada

cefoxitin for injection powder for solution

teva canada limited - cefoxitin (cefoxitin sodium) - powder for solution - 10g - cefoxitin (cefoxitin sodium) 10g - cephamycins